Stabilization of LKB1 and Akt by neddylation regulates energy metabolism in liver cancer
Open accessThe DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
// Lucía Barbier-Torres 1 , Teresa C. Delgado 1 , Juan L. García-Rodríguez 1 , Imanol Zubiete-Franco 1 , David Fernández-Ramos 1 , Xabier Buqué 2 , Ainara Cano 3 , Virginia Gutiérrez-de Juan 1 , Itziar Fernández-Domínguez 1 , Fernando Lopitz-Otsoa 1 , Pablo Fernández-Tussy 1 , Loreto Boix 4,5 , Jordi Bruix 4,5 , Erica Villa 6 , Azucena Castro 3 , Shelly C. Lu 7 , Patricia Aspichueta 2 , Dimitris Xirodimas 8 , Marta Varela-Rey 1 , José M. Mato 1 , Naiara Beraza 1 and María L. Martínez-Chantar 1 1 CIC bioGUNE, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Bizkaia Science and Technology Park, Derio, Bizkaia, Spain 2 Department of Physiology, University of the Basque Country UPV/EHU, Faculty of Medicine and Dentistry, Leioa, Bizkaia, Spain 3 OWL, Bizkaia Science and Technology Park, Derio, Bizkaia, Spain 4 Barcelona-Clínic Liver Cancer Group, Institut d’Investigacions Biomèdiques August Pi I Sunyer, Liver Unit, Hospital Clínic, Universitat de Barcelona, Barcelona, Catalonia, Spain 5 Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBERehd), Instituto de Salud Carlos III, Madrid, Spain 6 Department of Gastroenterology, Azienda Ospedaliero-Universitaria & University of Modena and Reggio Emilia, Modena, Italy 7 Division of Gastroenterology, Cedars-Sinai Medical Center, Los Angeles, CA, USC Research Center for Liver Diseases, Keck School of Medicine, Los Angeles, CA, USA 8 Centre de Recherche de Biochimie Macromoléculaire, Montpellier, France Correspondence: María L. Martínez-Chantar, email: // Keywords : Neddylation; Cancer metabolism; Hepatocellular Carcinoma; LKB1; Akt Received : September 26, 2014 Accepted : December 10, 2014 Published : December 11, 2014 Abstract The current view of cancer progression highlights that cancer cells must undergo through a post-translational regulation and metabolic reprogramming to progress in an unfriendly environment. In here, the importance of neddylation modification in liver cancer was investigated. We found that hepatic neddylation was specifically enriched in liver cancer patients with bad prognosis. In addition, the treatment with the neddylation inhibitor MLN4924 in Phb1 -KO mice, an animal model of hepatocellular carcinoma showing elevated neddylation, reverted the malignant phenotype. Tumor cell death in vivo translating into liver tumor regression was associated with augmented phosphatidylcholine synthesis by the PEMT pathway, known as a liver-specific tumor suppressor, and restored mitochondrial function and TCA cycle flux. Otherwise, in protumoral hepatocytes, neddylation inhibition resulted in metabolic reprogramming rendering a decrease in oxidative phosphorylation and concomitant tumor cell apoptosis. Moreover, Akt and LKB1, hallmarks of proliferative metabolism, were altered in liver cancer being new targets of neddylation. Importantly, we show that neddylation-induced metabolic reprogramming and apoptosis were dependent on LKB1 and Akt stabilization. Overall, our results implicate neddylation/signaling/metabolism, partly mediated by LKB1 and Akt, in the development of liver cancer, paving the way for novel therapeutic approaches targeting neddylation in hepatocellular carcinoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
Maemondo, M., Inoue, A., Kobayashi, K., Sugawara, S., Oizumi, S., Isobe, H., Gemma, A., Harada, M., Yoshizawa, H., Kinoshita, I., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909530 · Cited by 5,525
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Engelman, J. A., Luo, J., & Cantley, L. C. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1879 · Cited by 3,330 · cited 2×
“However, the activity of both kinases has been associated with HCC development [11-14].”
BackgroundProtein kinase C and lipid signaling for sustained cellular responses
Nishizuka, Y. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.7.7737456 · Cited by 2,499
Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-α prolyl hydroxylase
Selak, M. A., Armour, S. M., MacKenzie, E. D., Boulahbel, H., Watson, D. G., Mansfield, K. D., Pan, Y., Simon, M. C., Thompson, C. B., & Gottlieb, E. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.11.022 · Cited by 2,108
An inhibitor of NEDD8-activating enzyme as a new approach to treat cancer
Soucy, T. A., Smith, P. G., Milhollen, M. A., Berger, A. J., Gavin, J. M., Adhikari, S., Brownell, J. E., Burke, K. E., Cardin, D. P., Critchley, S., et al. (2009) · Nature · doi:10.1038/nature07884 · Cited by 1,990
The LKB1-AMPK pathway: metabolism and growth control in tumour suppression
Shackelford, D. B., & Shaw, R. J. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2676 · Cited by 1,943 · cited 1×
“LKB1 directly phosphorylates and activates AMP-activated protein kinase (AMPK), a central metabolic sensor [10].”
BackgroundSuccinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer
King, A., Selak, M. A., & Gottlieb, E. (2006) · Oncogene · doi:10.1038/sj.onc.1209594 · Cited by 672
Regulation of nucleolar signalling to p53 through NEDDylation of L11
Sundqvist, A., Liu, G., Mirsaliotis, A., & Xirodimas, D. P. (2009) · The EMBO Reports · doi:10.1038/embor.2009.178 · Cited by 132 · cited 1×
“Although the cullin-RING family of E3 ubiquitin-ligases are the bestcharacterized Nedd8 substrates, other proteins have been reported to be modified by Nedd8, including p53, murine double minute 2 (Mdm2), epidermal growth factor receptor, VHL tumour suppressor protein, L11, and other RNA binding proteins such as human…”
BackgroundSelf-citation
Cited by
Regulating tumor suppressor genes: post-translational modifications
Chen, L., Liu, S., & Tao, Y. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0196-9 · Cited by 449
Loss of Tumor Suppressor Gene Function in Human Cancer: An Overview
Wang, L.-H., Wu, C.-F., Rajasekaran, N., & Shin, Y. K. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000495956 · Cited by 334
Protein neddylation and its role in health and diseases
Zhang, S., Yu, Q., Li, Z., Zhao, Y., & Sun, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01800-9 · Cited by 171
“333 The tumor suppressor, RhoB (a Rho family member of small GTPases) was identi fi ed as the substrate of the neddylation-CRL pathway.”
BackgroundControlling the master—upstream regulation of the tumor suppressor LKB1
Kullmann, L., & Krahn, M. P. (2018) · Oncogene · doi:10.1038/s41388-018-0145-z · Cited by 75
Metadata
- Authors
- Barbier-Torres, L., Delgado, T. C., García-Rodríguez, J. L., Zubiete-Franco, I., Fernández-Ramos, D., Buqué, X., Cano, A., Juan, V. G.-D., Fernández-Domínguez, I., Lopitz-Otsoa, F., Fernández-Tussy, P., Boix, L., Bruix, J., Villa, E., Castro, A., Lu, S. C., Aspichueta, P., Xirodimas, D., Varela-Rey, M., Mato, J. M., Beraza, N., & Martínez-Chantar, M. L.
- Venue
- Oncotarget
- Publisher
- Impact Journals, LLC
- Published
- 2014-12-11
- Volume
- 6
- Issue
- 4
- Pages
- 2509-2523
- ISSN
- 1949-2553 (ISSN-L)
- OpenAlex
- W1598608016
- Cited by
- 87
- References
- 8
- FWCI
- 1.58
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Stabilization of LKB1 and Akt by neddylation regulates energy metabolism in liver cancer. https://app.cochat.ai/papers/10.18632/oncotarget.3191
- The paper
- Barbier-Torres, L., Delgado, T. C., García-Rodríguez, J. L., Zubiete-Franco, I., Fernández-Ramos, D., Buqué, X., Cano, A., Juan, V. G.-D., Fernández-Domínguez, I., Lopitz-Otsoa, F., Fernández-Tussy, P., Boix, L., Bruix, J., Villa, E., Castro, A., Lu, S. C., Aspichueta, P., Xirodimas, D., Varela-Rey, M., . . . Martínez-Chantar, M. L. (2015). Stabilization of LKB1 and Akt by neddylation regulates energy metabolism in liver cancer. Oncotarget. https://doi.org/10.18632/oncotarget.3191
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.